News
-
-
-
COMMUNIQUÉ DE PRESSE
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding a decrease in shareholding percentage. The company is focused on technology-enabled clinical research and software platform -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Oxurion élargit sa plateforme de recherche clinique grâce à un partenariat stratégique en biométrie entre Axiodis CRO et KYomed INNOV
Oxurion NV annonce un partenariat avec KYomed INNOV & CEISO pour offrir des services spécialisés de biométrie soutenant le développement clinique. Le partenariat renforce la plateforme technologique de recherche clinique d'Oxurion -
COMMUNIQUÉ DE PRESSE
Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV
Oxurion NV announces strategic partnership with KYomed INNOV & CEISO for specialist biometrics services in clinical development, aiming to optimize study design and data quality
